An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage

Circulating tumor DNA (ctDNA) represents a promising biomarker for noninvasive assessment of cancer burden, but existing methods have insufficient sensitivity or patient coverage for broad clinical applicability. Here we introduce CAncer Personalized Profiling by deep Sequencing (CAPP-Seq), an econo...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Newman, Aaron M., Bratman, Scott V., To, Jacqueline, Wynne, Jacob F., Eclov, Neville C. W., Modlin, Leslie A., Liu, Chih Long, Neal, Joel W., Wakelee, Heather A., Merritt, Robert E., Shrager, Joseph B., Loo, Billy W., Alizadeh, Ash A., Diehn, Maximilian
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2014
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4016134/
https://ncbi.nlm.nih.gov/pubmed/24705333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nm.3519
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak